All articles by Rebecca Trager – Page 65
-
BusinessGenerics firms in three-way takeover battle
Mylan is chasing Perrigo, while fending off advances from Teva
-
ResearchAnton Toutov: The power of potassium
Anton Toutov discusses how using potassium to make silicon-containing organic chemicals has shaken up chemistry
-
NewsUS environment body criticised for persecuting 9/11 dust whistleblower
Agency withheld evidence exonerating a senior chemist who was fired several years ago, judge rules
-
NewsHigh hopes for ACS cannabis division
An effort to create a cannabis division within the American Chemical Society is gaining momentum
-
NewsScience skirmishes continue on Capitol Hill
Republican research funding bill faces opposition from science and academic research groups
-
NewsEmerging from Deepwater
Five years after a BP oil rig explosion spewed millions of oil barrels into the Gulf of Mexico, key questions remain
-
ResearchPlant molecule could create ‘greener’ roads
Lignin could be turned into a more environmentally friendly and sustainable tarmac by replacing some bitumen
-
ResearchSewage offers attractive source of precious metals
US Geological Survey team finds valuable metals in treated sewage and is working on the difficult problem of extraction
-
News
Chemists in demand as cannabis industry experiences explosive growth
Legalisation of marijuana in some US states is fuelling demand for analytical specialists
-
News
Reform of US chemical safety rules back on
Bipartisan bill to revamp the US Toxic Substances Control Act is backed by the chemical industry and even a major environmental group
-
ResearchOpossum peptide antivenom could take on snake bites
An opossum serum protein that neutralises snake venom could offer a cheaper treatment for poisonous snake bites worldwide
-
ResearchBacterium altered to suppress hunger faces long road to clinic
Engineered microbes produce anti-obesity molecule in mice, but moving to humans poses challenges
-
NewsSplit opens up on Capitol Hill over science funding
Criticism of research grants and a power shift in Congress spark concern that budgets and independence will be cut
-
Business
Drug firms warned to be honest with investors
Official warns of ‘significant consequences’ if companies aren’t forthcoming about their FDA interactions
-
NewsTitanium dioxide removed from Dunkin' Donuts sugar
Parent company agrees to remove whitener from icing sugar used on its doughnuts after public campaign
-
Business
Amgen to axe 300 Onyx employees
Amgen will close its Onyx facility in South San Francisco in December
-
Business
Mergers and moves trigger pharma layoffs
Shire expects to sack 500 or more employees, while Merck and GSK also wield the axe
-
NewsUS chemical safety board in turmoil
The US agency that investigates chemical accidents faces heavy criticism, and its chairman is under pressure to resign
-
Business
US approves biosimilar filgrastim
Sandoz’s version of Amgen’s Neupogen is ‘biosimilar’ but not ‘interchangeable’
-
News
US universities back new bill to curb patent trolls
Academic research community endorses competing legislation as harmless to university tech transfer